HCM
HUTCHMED
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$13.67
−1.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 43.45x
- P/E 2027E
- 26.29x
- P/E 2028E
- 24.83x
- P/S forward
- 3.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- 139.49x
- PEG TTM
- —
- Price / book
- 1.89x
- Price / sales
- 4.34x
- Price / cash flow
- 116.57x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 2.03x
- EV / EBITDA
- -54.46x
- EV / EBIT
- -32.12x
- Market cap
- $2.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026